ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 1: Certain infectious and parasitic diseasesA15

A15

Non-billable

Respiratory tuberculosis

Chapter 1:Certain infectious and parasitic diseases

BILLABLE STATUSNo
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 A15 is a used to indicate a diagnosis of respiratory tuberculosis.

Key Diagnostic Point:

Respiratory tuberculosis (TB) is a contagious bacterial infection caused by Mycobacterium tuberculosis, primarily affecting the lungs but can also involve other parts of the body. The disease is transmitted through airborne droplets when an infected person coughs, sneezes, or talks. Symptoms typically include a persistent cough, chest pain, hemoptysis (coughing up blood), fever, night sweats, and weight loss. Diagnosis is primarily made through clinical evaluation, chest X-rays, and microbiological tests such as sputum smear microscopy and culture. Molecular tests like the GeneXpert can also be utilized for rapid diagnosis. Treatment involves a prolonged course of antibiotics, typically including isoniazid, rifampicin, ethambutol, and pyrazinamide, administered over a minimum of six months. Monitoring for treatment adherence and potential drug resistance is crucial, as multidrug-resistant TB (MDR-TB) poses significant public health challenges. Isolation procedures may be necessary for patients with active TB to prevent transmission, and contact tracing is essential to identify and treat exposed individuals. Public health implications include the need for vaccination programs, particularly with the BCG vaccine, and ongoing surveillance to control outbreaks.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in clinical presentation and symptoms
  • Need for accurate documentation of diagnostic tests
  • Potential for drug-resistant strains complicating treatment
  • Public health reporting requirements

Audit Risk Factors

  • Inadequate documentation of diagnostic tests
  • Failure to report drug resistance
  • Lack of detailed treatment plans
  • Insufficient follow-up documentation

Specialty Focus

Medical Specialties

Pulmonology

Documentation Requirements

Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.

Common Clinical Scenarios

Patients presenting with chronic cough, hemoptysis, or abnormal chest X-ray findings.

Billing Considerations

Need for comprehensive documentation of sputum tests and follow-up imaging.

Infectious Disease

Documentation Requirements

Thorough documentation of exposure history, treatment regimens, and drug susceptibility testing.

Common Clinical Scenarios

Management of patients with MDR-TB or those requiring complex treatment regimens.

Billing Considerations

Importance of documenting public health notifications and contact tracing efforts.

Coding Guidelines

Inclusion Criteria

Use A15 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the diagnosis, treatment, and any complications
  • Include specific details about the type of TB (e
  • , drug
  • resistant) and any associated conditions

Exclusion Criteria

Do NOT use A15 When
No specific exclusions found.

Related CPT Codes

86580CPT Code

Tuberculosis skin test

Clinical Scenario

Used for screening individuals at high risk for TB.

Documentation Requirements

Document the reason for testing and results.

Specialty Considerations

Pulmonologists may order this test for patients with respiratory symptoms.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of tuberculosis cases, improving the ability to track and manage the disease. It has also emphasized the importance of documenting drug resistance and public health implications.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of tuberculosis cases, improving the ability to track and manage the disease. It has also emphasized the importance of documenting drug resistance and public health implications.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of tuberculosis cases, improving the ability to track and manage the disease. It has also emphasized the importance of documenting drug resistance and public health implications.

Resources

Clinical References

  • •
    CDC Tuberculosis (TB) Fact Sheet

Coding & Billing References

  • •
    CDC Tuberculosis (TB) Fact Sheet

Frequently Asked Questions

What is the difference between latent and active tuberculosis?

Latent TB is when the bacteria are present in the body but inactive, causing no symptoms and not being contagious. Active TB is when the bacteria are active, causing symptoms and can be transmitted to others.